基本數據
| CIK | 1068874 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Implant Sciences Corp.
SEC Filings (Chronological Order)
本頁面提供了一個完整的、按時間順序排列的美國證券交易委員會（SEC）申報文件列表，不包括我們在其他地方提供的所有權申報。
| March 25, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. SECURITIES EXCHANGE ACT OF 1934 Release No. 99837 / March 22, 2024 Admin. Proc. File No. 3-21680 In the Matter of SECURE POINT TECHNOLOGIES, INC. OPINION OF THE COMMISSION SECTION 12(j) PROCEEDING Grounds for Remedial Action Failure to Comply with Periodic Filing Requirements Company failed to file periodic reports in violation of Section 13(a) o |
|
| August 1, 2017 |
Financial Statements and Exhibits, Bankruptcy or Receivership Final Revised 8-K 07 31 2017 (00525963).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 7, 2017 SECURE POINT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdic |
|
| July 10, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K (LOI) (00519483-3).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 10, 2017 SECURE POINT TECHNOLOGIES, INC. (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorpor |
|
| July 10, 2017 |
Secure Point Technologies, Inc. 215 Depot Court Leesburg, VA 20175 EX-99.1 2 imsc170707ex99z1.htm EXHIBIT 99.1 Secure Point Technologies, Inc. 215 Depot Court Leesburg, VA 20175 703-407-9437 June 20, 2017 Vivos BioTechnologies, Inc. 605 West Knox Road, Suite 102 Tempe, AZ 85284 Attn: R. Kirk Huntsman Re: Transaction with Secure Point Technologies, Inc. Dear Kirk: The purpose of this letter is to confirm our mutual agreement in principle whereby Vivos BioTechnolog |
|
| July 10, 2017 |
Converted by EDGARwiz Secure Point Technologies (IMSCQ) Signs a Letter of Intent to Merge With Vivos BioTechnologies Vivos markets an FDA cleared device that has been shown effective in the potentially permanent resolution of Obstructive Sleep Apnea (OSA). |
|
| May 30, 2017 |
IMSC / Implant Sciences Corp. 170331 IMSCQ FORM 10-Q (Quarterly Report) 10-Q 1 imsc17033110q.htm 170331 IMSCQ FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the quarterly period ended March 31, 2017 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Comm |
|
| May 25, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 25, 2017 |
Secure Point Technologies, Inc. Responds to Zapata Industries Baseless and False Allegations Converted by EDGARwiz Exhibit 99.1 Secure Point Technologies, Inc. Responds to Zapata Industries Baseless and False Allegations Leesburg, Virginia - May 25, 2017 - On May 9, 2017, Zapata Industries SAS (?Zapata?) filed a complaint in the Supreme Court of the State of New York, New York County, against Robert Liscouski, the President and a member of the Board of Directors of Secure Point Technologi |
|
| May 19, 2017 |
Secure Point Technologies, Inc. Responds to Zapata Industries Baseless and False Allegations Converted by EDGARwiz Exhibit 99.1 Secure Point Technologies, Inc. Responds to Zapata Industries Baseless and False Allegations Leesburg, Virginia - May 19, 2017 - On May 9, 2017, Zapata Industries SAS (?Zapata?) filed a complaint in the Supreme Court of the State of New York, New York County, against Robert Liscouski, the President and a member of the Board of Directors of Secure Point Technologi |
|
| May 19, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 15, 2017 |
Implant Sciences 170515 IMSCQ FORM 12B-25 FOR 170331 FORM 10-Q Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on |
|
| February 21, 2017 |
AMENDMENT NO. 4 TO ASSET PURCHASE AGREEMENT Converted by EDGARwiz Exhibit 2.5 AMENDMENT NO. 4 TO ASSET PURCHASE AGREEMENT This AMENDMENT NO. 4 TO ASSET PURCHASE AGREEMENT (this ?Amendment?) is dated as of December 16, 2016, by and among Implant Sciences Corporation, a Massachusetts corporation (the ?Company?), C ACQUISITION CORP., a Delaware corporation, ACCUREL SYSTEMS INTERNATIONAL CORPORATION, a California corporation, and IMX ACQUISITIO |
|
| February 21, 2017 |
AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT EX-2.4 2 imsc10qex2z4.htm EXHIBIT 2.4 Exhibit 2.4 AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT This AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT (this “Amendment”) is dated as of November 15, 2016, by and among Implant Sciences Corporation, a Massachusetts corporation (the “Company”), C ACQUISITION CORP., a Delaware corporation, ACCUREL SYSTEMS INTERNATIONAL CORPORATION, a California corporation, an |
|
| February 21, 2017 |
Implant Sciences 161231 IMSCQ FORM 10-Q (Quarterly Report) 10-Q 1 imsc16123110q.htm 161231 IMSCQ FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to |
|
| February 13, 2017 |
Implant Sciences 161231 FORM 12B-25 FOR FORM 10-Q Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report |
|
| January 13, 2017 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 13, 2017 |
EX-10.1 2 imsc170113ex10z1.htm EXHIBIT 10.1 Exhibit 10.1 SECURE POINT TECHNOLOGIES, INC. c/o Richard Anslow, Esq. Ellenoff Grossman & Schole LLP 1345 Avenue of the Americas, 11th Floor New York, NY 10105 January 5, 2017 Mr. Christopher Roberts 1014 Priory Place McLean, VA 22101 Re: Services Agreement Dear Mr. Roberts: This letter agreement (this “Agreement”) sets forth the terms and conditions whe |
|
| January 6, 2017 |
8-K 1 imsc1701068k.htm 170106 IMSCQ FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 5, 2017 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdic |
|
| January 6, 2017 |
Converted by EDGARwiz Secure Point Technologies, Inc. (f/k/a Implant Sciences Corporation) Announces Closing of Sale of ETD Assets to L3 Communications Wilmington, MA January 6, 2017 Secure Point Technologies, Inc. (f/k/a Implant Sciences Corporation) (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions, announced today that on January 5, 2017 it completed the sal |
|
| December 23, 2016 |
Implant Sciences 160930 IMSCQ FORM 10-Q (Quarterly Report) 10-Q 1 imsc16093010q.htm 160930 IMSCQ FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to |
|
| December 23, 2016 |
Converted by EDGARwiz Exhibit 10.4 AGREEMENT This Agreement (Agreement), dated of September , 2016, is made by and between Implant Sciences Corporation, with a principal place of business at 500 Research Drive, Unit 3, Wilmington, MA 01887; and ROBERT LISCOUSKI, an individual, with an address at (Liscouski). WHEREAS, Implant Sciences Corporation (hereinafter IMSC) is in the process of sellin |
|
| December 1, 2016 |
Termination of a Material Definitive Agreement 8-K 1 imsc1612018k.htm 161201 IMSC FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2016 (November 21, 2016) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (Sta |
|
| November 14, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 14, 2016 |
Converted by EDGARwiz Exhibit 10.1 $8,000,000 SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT by and among IMPLANT SCIENCES CORPORATION, C ACQUISITION CORP., ACCUREL SYSTEMS INTERNATIONAL CORPORATION, and IMX ACQUISITION CORP. as the Borrower, and TANNOR PARTNERS CREDIT FUND, LP as the DIP Lender Dated as of November 7, 2016 SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN- |
|
| November 14, 2016 |
Implant Sciences 160930 IMSCQ FORM 12B-25 Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Repor |
|
| November 4, 2016 |
AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT Converted by EDGARwiz Exhibit 2.2 AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT This AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT (this ?Amendment?) is dated as of October 28, 2016, by and among Implant Sciences Corporation, a Massachusetts corporation (the ?Company?), C ACQUISITION CORP., a Delaware corporation, ACCUREL SYSTEMS INTERNATIONAL CORPORATION, a California corporation, and IMX ACQUISITION |
|
| November 4, 2016 |
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT EX-2.1 2 imsc161104ex2z1.htm EXHIBIT 2.1 EXECUTION VERSION Exhibit 2.1 AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT This AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (this “Amendment”) is dated as of October 20, 2016, by and among Implant Sciences Corporation, a Massachusetts corporation (the “Company”), C ACQUISITION CORP., a Delaware corporation, ACCUREL SYSTEMS INTERNATIONAL CORPORATION, a Califo |
|
| November 4, 2016 |
FIRST AMENDMENT TO SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT Converted by EDGARwiz Exhibit 10.1 FIRST AMENDMENT TO SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT THIS FIRST AMENDMENT TO SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT (this ?Agreement?), entered into as of November 3, 2016, is made and entered into by and among DIP SPV I, L.P. (?DIP Lender?) and IMPLANT SCIENCES CORPORATION, C |
|
| November 4, 2016 |
8-K 1 imsc1611048k.htm 161104 IMSCQ FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 4, 2016 (October 28, 2016) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (Sta |
|
| October 28, 2016 |
Implant Sciences 160630 IMSC FORM 10-K/A NO. 1 (Annual Report) Form 10-K - FY 2014 - Part III (M0696383.DOC;2) U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Com |
|
| October 14, 2016 |
Converted by EDGARwiz EXECUTION VERSION Exhibit 2.1 ASSET PURCHASE AGREEMENT among IMPLANT SCIENCES CORPORATION C ACQUISITION CORP. ACCUREL SYSTEMS INTERNATIONAL CORPORATION and IMX ACQUISITION CORP. as the Sellers and L-3 COMMUNICATIONS CORPORATION as Buyer Dated as of October 10, 2016 This document is not intended to create nor will it be deemed to create a legally binding or enforceable offer o |
|
| October 14, 2016 |
Converted by EDGARwiz Execution Copy Exhibit 10.1 $5,700,000 SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-POSSESSION LOAN AND SECURITY AGREEMENT by and among IMPLANT SCIENCES CORPORATION, C ACQUISITION CORP., ACCRUEL SYSTEMS INTERNATIONAL CORPORATION, and IMX ACQUISITION CORP. as the Borrower, and DIP SPV I, L.P. as the DIP Lender Dated as of October 10, 2016 SENIOR SECURED, SUPER-PRIORITY DEBTOR-IN-P |
|
| October 14, 2016 |
8-K 1 imsc1610148k.htm 161014 IMSC FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 10, 2016 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdict |
|
| October 14, 2016 |
Exhibit 99.1 Implant Sciences Corporation Announces Annual Shareholder Meeting Consideration of Alternatives and Opportunities Following the Completion of the Sale of its ETD Assets Wilmington, MA – October 13, 2016 – Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions, announced today that there will be a shareholder meeting anticipated |
|
| October 13, 2016 |
Implant Sciences 160630 IMSC FORM 10K (Annual Report) IMSC Form 10K Template U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences |
|
| October 11, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits, Bankruptcy or Receivership Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 11, 2016 |
Converted by EDGARwiz Exhibit 99.1 L-3 Agrees to Acquire Implant Sciences Explosives Trace Detection Assets ? Leader in the Design and Manufacture of Explosives Trace Detection (ETD) Systems and Sensors for Homeland Security and Defense Markets ? Wilmington MA, October 10, 2016 ? Implant Sciences (IMSC) announced today that it has entered into an asset purchase agreement to sell the explosives tra |
|
| September 28, 2016 |
Implant Sciences 160928 IMSC FORM 12B-25 FOR 160630 FORM 10-Q Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on |
|
| September 16, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 16, 2016 |
Implant Sciences Receives New Delivery Order from TSA for 1,353 Explosive Trace Detectors Converted by EDGARwiz Exhibit 99.1 Implant Sciences Receives New Delivery Order from TSA for 1,353 Explosive Trace Detectors WILMINGTON, Mass., Sept.15, 2016 - Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed a delivery order |
|
| August 10, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 10, 2016 |
Event Transcript Exhibit 99.2 CORPORATE PARTICIPANTS Bob Liscouski Implant Sciences Corporation - President Roger Deschenes Implant Sciences Corporation - CFO Cheryl Debelis Implant Sciences Corporation - Director of Marketing Franky Zapata Zapata Industries - CEO PRESENTATION Operator Good day, ladies and gentlemen, and welcome to the Implant Sciences Corporation and Zapata Industries Update Call |
|
| August 10, 2016 |
Event Transcript Exhibit 99.2 CORPORATE PARTICIPANTS Bob Liscouski Implant Sciences Corporation - President Roger Deschenes Implant Sciences Corporation - CFO Cheryl Debelis Implant Sciences Corporation - Director of Marketing Franky Zapata Zapata Industries - CEO PRESENTATION Operator Good day, ladies and gentlemen, and welcome to the Implant Sciences Corporation and Zapata Industries Update Call |
|
| August 10, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 10, 2016 |
IMSCSchiphol PR (00355826-2).DOCX Exhibit 99.1 Implant Sciences Announces Conference Call and Q&A Regarding Zapata Industries Company to Host Conference Call Thursday August 4, 2016 at 4:15pm Wilmington, MA ? August 3, 2016 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today |
|
| August 1, 2016 |
IMSCSchiphol PR (00355826-2).DOCX Exhibit 99.1 Implant Sciences Announces Conference Call Regarding Zapata Industries Company to Host Conference Call Monday, July 25th at 4:15 pm EST Wilmington, MA ? July 25, 2016 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced |
|
| August 1, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 1, 2016 |
Converted by EDGARwiz Exhibit 99.2 Implant Sciences Update Call July 25, 2016 C: Bill McGann; Implant Sciences; CEO C: Roger Deschenes; Implant Sciences; CFO C: Bob Liscouski; Implant Sciences; President +++ presentation Operator^ Good day, ladies and gentlemen, and welcome to Implant Sciences Update Conference Call. At this time, all participants are in a listen-only mode. (Operator Instructions) |
|
| July 22, 2016 |
8-K 1 imsc1607228k.htm IMSC FORM 8K (160722) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 22, 2016 (July 18, 2016) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or |
|
| July 22, 2016 |
Converted by EDGARwiz Exhibit 3.3 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 500 Research Drive, Unit 3, Wilmington, MA 01887 (num |
|
| July 22, 2016 |
Converted by EDGARwiz Exhibit 3.1 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 500 Research Drive, Unit 3, Wilmington, MA 01887 (num |
|
| July 22, 2016 |
EX-10.2 7 imsc160722ex10z2.htm EXHIBIT 10.2 Exhibit 10.2 EXCEPT AS SET FORTH BELOW UNDER THE PARAGRAPH HEADINGS “REIMBURSEMENT AND PAYMENT”, “NO SHOP”, “CONDUCT OF BUSINESS; ACCESS”, “CONFIDENTIALITY”, “EXPENSES”, “PUBLICITY” AND “GOVERNING LAW; JURISDICTION; WAIVER OF JURY TRIAL; MISCELLANEOUS” (THE TERMS AND CONDITIONS OF WHICH ARE INTENDED TO BE AND SHALL BE LEGALLY BINDING ON THE PARTIES), THI |
|
| July 22, 2016 |
Converted by EDGARwiz Exhibit 3.2 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 500 Research Drive, Unit 3, Wilmington, MA 01887 (num |
|
| July 22, 2016 |
IMSCSchiphol PR (00355826-2).DOCX Exhibit 99.1 Implant Sciences Announces Letter of Intent to Acquire Zapata Industries, Plan to Extinguish Debt and Uplist to NASDAQ Zapata's Breakthrough Disruptive Technology Makes Personal Flight a Commercial Reality - the Dawn of an Exciting New Industry Wilmington, MA ? July 21, 2016 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explos |
|
| July 22, 2016 |
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF IMPLANT SCIENCES CORPORATION Expires July 20, 2021 EX-4.4 5 imsc160722ex4z4.htm EXHIBIT 4.4 Exhibit 4.4 THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR IMP |
|
| July 22, 2016 |
Converted by EDGARwiz Exhibit 10.1 OMNIBUS FIFTEENTH AMENDMENT TO CREDIT AGREEMENT AND SEVENTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Fifteenth Amendment to Credit Agreement and Seventeenth Amendment to Note and Warrant Purchase Agreement (Amendment) is dated as of July 20, 2016 and effective as of June 30, 2016, by and among Implant Sciences Corporation, a Massachuset |
|
| July 22, 2016 |
Implant Sciences Extends Credit Agreements EX-99.2 9 imsc160722ex99z2.htm EXHIBIT 99.2 Exhibit 99.2 Implant Sciences Extends Credit Agreements Wilmington, MA – July 21, 2016 – Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, today announced the extension of its secured credit agreements with DMRJ Group, LLC (DMRJ) and Mont |
|
| July 20, 2016 |
SC 13D/A 1 issch13dajul2016.htm PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP SC 13D/A 4-6-2016 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-1) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(A) (Amendment No. 1)* IMPLANT SCIENCES CORPORATION (Name of Issuer) Common Stock, par value $0.10 |
|
| May 31, 2016 |
Implant Sciences 160531 IMSC FORM SD Form 10-Q - 2014 Q1 (M0590221.DOC;3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Implant Sciences Corporation (Exact name of registrant as specified in its charter) Massachusetts 001-14949 04-2837126 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 500 Research |
|
| May 31, 2016 |
Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2015 Converted by EDGARwiz Exhibit 1.01 Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2015 1. Background The United States Securities and Exchange Commission (SEC) adopted rules, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (Dodd-Frank), that require us to file with the SEC a report disclosing whether our products contain |
|
| May 19, 2016 |
8-K 1 imsc1605198k.htm 160519 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 19, 2016 (May 16, 2016) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Ju |
|
| May 19, 2016 |
IMSC3Patents PR (EGS 5.8.15) (00359966).DOCX Exhibit 99.1 IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2016 FINANCIAL RESULTS · Quarterly revenue increased 230.5% to $10.9 million · Nine months revenue increased 386.8% to $35.6 million Wilmington, MA May 16, 2016 Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection sol |
|
| May 19, 2016 |
Q3 2016 Implant Sciences Corporation Earnings Conference Call 139469570991 Exhibit 99.2 Q3 2016 Implant Sciences Corporation Earnings Conference Call May 16, 2016 C: William McGann; Implant Sciences Corporation; CEO C: Roger Deschenes; Implant Sciences Corporation; CFO C: Todd Silvestri; Implant Sciences Corporation; COO P: Mark Jordan; Noble Essential; Analyst P: Peter Banice;; Private Investor P: Jim Shens;; Private Investor P: Chris Theodore;; Private Inv |
|
| May 16, 2016 |
Implant Sciences 160331 FORM 10-Q (Quarterly Report) 10-Q 1 imsc16033110q.htm 160331 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commissio |
|
| May 16, 2016 |
FIRST AMENDMENT TO ACCOUNTS RECEIVABLE PURCHASE AGREEMENT EX-10.4 2 imsc10qex10z4.htm EXHIBIT 10.4 Exhibit 10.4 FIRST AMENDMENT TO ACCOUNTS RECEIVABLE PURCHASE AGREEMENT THIS FIRST AMENDMENT TO ACCOUNTS RECEIVABLE PURCHASE AGREEMENT, dated as of April 11, 2016 (this “Amendment”), between Republic Capital Access, LLC, a Delaware limited liability company (“RCA”), and Implant Sciences Corporation, a Massachusetts corporation (“Seller”). Capitalized terms u |
|
| April 18, 2016 |
POWER OF ATTORNEY IMPLANT SCIENCES CORPORATION SECTION 16(a) FILINGS Exhibit 24 POWER OF ATTORNEY FOR IMPLANT SCIENCES CORPORATION SECTION 16(a) FILINGS Know all by these presents that the undersigned hereby constitutes and appoints Joseph SanFilippo as the undersigned?s true and lawful attorney-in-fact to: (1) Prepare, execute in the undersigned's name and on the undersigned?s behalf, and submit to the U. |
|
| April 18, 2016 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d2(a) (Amendment No. )* IMPLANT SCIENCES CORPORATION (Name of Issuer) Common Stock, par value $0.10 per share (Title of Class of Securities) 45320R108 (CUSIP Number) Joseph SanFilippo Chief Fina |
|
| April 18, 2016 |
EX-99.1 2 v437242ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 AGREEMENT JOINT FILING OF SCHEDULE 13D The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of Implant Sciences Corporation, and hereby affirm that such Schedule 13D is being filed on behalf of each of the |
|
| April 8, 2016 |
Implant Sciences Extends Credit Agreements IMSCSchiphol PR (00355826-2).DOCX Exhibit 99.1 Implant Sciences Extends Credit Agreements Wilmington, MA March 31, 2016 Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security, today announced the extension of its secured credit agreements with DMRJ Group, LLC (DMRJ) and the group of inves |
|
| April 8, 2016 |
Form 8-K (President) (00382299-2).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 8, 2016 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of |
|
| April 8, 2016 |
Converted by EDGARwiz Exhibit 3.1 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 500 Research Drive, Unit 3, Wilmington, MA 01887 (num |
|
| April 8, 2016 |
EX-10.3 5 imsc160408ex10z3.htm EXHIBIT 10.3 Exhibit 10.3 March 31, 2016 DMRJ Group LLC Montsant Partners LLC Gentlemen: This letter (this “Comfort Letter”) is being provided to you, effective as of the date set forth above, in connection with the extension of the maturity date of our obligations under certain notes and security agreements that are more specifically described in the Fourteenth Omni |
|
| April 8, 2016 |
CONSENT AND SECOND OMNIBUS AMENDMENT TO SECURED TERM NOTES EX-10.1 3 imsc160408ex10z1.htm EXHIBIT 10.1 Exhibit 10.1 CONSENT AND SECOND OMNIBUS AMENDMENT TO SECURED TERM NOTES This Consent and Second Omnibus Amendment to Secured Term Notes (“Amendment”) is dated as of April 6, 2016 and effective as of March 30, 2016, by and among Implant Sciences Corporation, a Massachusetts corporation (the “Company”), C Acquisition Corp., a Delaware corporation (“C Acqui |
|
| April 8, 2016 |
Converted by EDGARwiz Exhibit 10.2 OMNIBUS FOURTEENTH AMENDMENT TO CREDIT AGREEMENT AND SIXTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Fourteenth Amendment to Credit Agreement and Sixteenth Amendment to Note and Warrant Purchase Agreement (?Amendment?) is dated as of April 6, 2016 and effective as of March 31, 2016, by and among Implant Sciences Corporation, a Massachusett |
|
| February 19, 2016 |
T, IMSC - Q2 2016 Implant Sciences Cor Sciences Earnings Call Event Transcript T, IMSC - Q2 2016 Implant Sciences Cor Sciences Earnings Call EBRUARY 11, 2016 / GMT, IMSC - Q2 2016 IMPLANT SCIENCES CORP EARNINGS Exhibit 99. |
|
| February 19, 2016 |
Form 8-K (M0592445.DOC;2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2016 (February 11, 2016) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Juris |
|
| February 19, 2016 |
EX-99.1 2 imsc160218ex99z1.htm EXHIBIT 99.1 Exhibit 99.1 IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2016 FINANCIAL RESULTS Quarterly revenue increase 380.7% to $10.3 million Six months revenue increase 515.6% to $24.7 million Wilmington, MA – February 11, 2016 – Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solut |
|
| February 16, 2016 |
Employment Agreement - McGannafasdfa (M0387982.DOC;4) Exhibit 10.9 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of this 15th day of December 2015, between Robert Liscouski (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. WHEREAS, the Company desires that for the foreseeable future the Executive will serve as the Company’s P |
|
| February 16, 2016 |
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT EX-10.5 3 imcs10qex10z5.htm EXHIBIT 10.5 Exhibit 10.5 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”), dated effective as of January 6, 2016 (the “Effective Date”), is by and between Implant Sciences Corporation (the “Company”), a Massachusetts corporation, and Darryl Jones (“Executive”). WHEREAS, the Company and Executive are parties to that |
|
| February 16, 2016 |
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT Converted by EDGARwiz Exhibit 10.6 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”), dated effective as of January 6, 2016 (the “Effective Date”), is by and between Implant Sciences Corporation (the “Company”), a Massachusetts corporation, and Todd Silvestri (“Executive”). WHEREAS, the Company and Executive are parties to that certain Employmen |
|
| February 16, 2016 |
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT Converted by EDGARwiz Exhibit 10.8 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”), dated effective as of January 6, 2016 (the “Effective Date”), is by and between Implant Sciences Corporation (the “Company”), a Massachusetts corporation, and Roger Deschenes (“Executive”). WHEREAS, the Company and Executive are parties to that certain Employme |
|
| February 16, 2016 |
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT Converted by EDGARwiz Exhibit 10.7 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”), dated effective as of January 6, 2016 (the “Effective Date”), is by and between Implant Sciences Corporation (the “Company”), a Massachusetts corporation, and Brenda Baron (“Executive”). WHEREAS, the Company and Executive are parties to that certain Employment |
|
| February 16, 2016 |
IMSC / Implant Sciences Corp. 10-Q - Quarterly Report - 151231 IMSC FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 X For the quarterly period ended December 31, 2015 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences |
|
| February 16, 2016 |
AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.4 2 imsc10qex10z4.htm EXHIBIT 10.4 Exhibit 10.4 AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Amendment”), dated effective as of January 6, 2016 (the “Effective Date”), is by and between Implant Sciences Corporation (the “Company”), a Massachusetts corporation, and William McGann (“Executive”). WHEREAS, th |
|
| January 4, 2016 |
8-K 1 imsc1601048k.htm 160104 IMSC FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 4, 2016 (December 22, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State |
|
| January 4, 2016 |
LIEN RELEASE AND AMENDMENT AGREEMENT Converted by EDGARwiz Exhibit 10.3 LIEN RELEASE AND AMENDMENT AGREEMENT THIS LIEN RELEASE AND AMENDMENT AGREEMENT (this ?Agreement?) is made and entered into this 22nd day of December, 2015, by Republic Capital Access, LLC (?RCA?), BAM Administrative Services, LLC (?Bank?) and Implant Sciences Corporation (?Customer?). WHEREAS, Bank has agreed to make certain financial accommodations to Customer. |
|
| January 4, 2016 |
EX-10.2 3 imsc160104ex10z2.htm EXHIBIT 10.2 Exhibit 10.2 LIEN RELEASE AGREEMENT THIS LIEN RELEASE AGREEMENT (this “Agreement”) is made and entered into this 17th day of December, 2015, by Republic Capital Access, LLC (“RCA”) and DMRJ Group, LLC (“Bank”). WHEREAS, Bank has agreed to make certain financial accommodations to Implant Sciences Corporation (the “Customer”); WHEREAS, in connection with s |
|
| January 4, 2016 |
ACCOUNTS RECEIVABLE PURCHASE AGREEMENT EX-10.1 2 imsc160104ex10z1.htm EXHIBIT 10.1 Exhibit 10.1 ACCOUNTS RECEIVABLE PURCHASE AGREEMENT THIS ACCOUNTS RECEIVABLE PURCHASE AGREEMENT (this “Agreement”) is made on this 11th day of December, 2015, by and between REPUBLIC CAPITAL ACCESS, LLC, a Delaware limited liability company having its principal place of business at 790 Station Street, Herndon, Virginia 20170 (“Buyer”), and IMPLANT SCIENC |
|
| November 18, 2015 |
IMSC3Patents PR (EGS 5.8.15) (00359966).DOCX Exhibit 99.1 IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2016 FINANCIAL RESULTS ? Record Revenues of $14.4 million ? Adjusted EBITDA Income of $2.1M or 14.9% of Revenues Wilmington, MA ? November 11, 2015 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (?ETD?) and drugs trace detection solutions for ho |
|
| November 18, 2015 |
EX-99.2 3 imsc151118ex99z2.htm EVENT TRANSCRIPT Exhibit 99.2 CORPORATE PARTICIPANTS William McGann Implant Sciences Corp. - CEO Roger Deschenes Implant Sciences Corp. - CFO, VP - Finance Todd Silvestri Implant Sciences Corp. - COO Darryl Jones Implant Sciences Corp. - EVP Robert Liscouski Implant Sciences Corp. - President CONFERENCE CALL PARTICIPANTS Mark Conrad Jordan Noble Financial Group - Ana |
|
| November 18, 2015 |
Form 8-K (M0592445.DOC;2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 18, 2015 (November 12, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Juris |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences |
|
| November 16, 2015 |
Implant Sciences Form 10-Q (Quarterly Report) Form 10-Q - 2014 Q1 (M0590221.DOC;3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission |
|
| November 9, 2015 |
Implant Sciences IMSC FORM 12B-25 FOR 150930 10-Q Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Repor |
|
| October 27, 2015 |
Form 10-K - FY 2014 - Part III (M0696383.DOC;2) U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2) (Mark One) ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Co |
|
| October 27, 2015 |
Implant Sciences Form 10-K/A (Annual Report) 10-K/A 1 imsc15063010ka210kz.htm 150630 IMSC FORM 10-K/A#2 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2) (Mark One) ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period |
|
| October 5, 2015 |
Exhibit 10.18 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of this 16th day of September 2015, between Roger Deschenes (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to continue to employ Executive, and Executive hereby accepts employment with the Company, upon the terms se |
|
| October 5, 2015 |
Exhibit 10.65 ASSIGNMENT AGREEMENT This Assignment Agreement (this “Agreement”) is made effective as of May 4 2015 (the “Effective Date”) by and between DMRJ Group LLC (the “Assignor”) and Montsant Partners LLC (the “Assignee”). All capitalized terms used in this Agreement and not otherwise defined herein will have the respective meanings set forth in the Purchase Agreement as hereinafter defined. |
|
| October 5, 2015 |
AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.15 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Amended Agreement”), is entered into as of the 16th day of January 2015 by and between William McGann (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. WHEREAS, the Company and the Executive previously entered into an Employment Agreement on March |
|
| October 5, 2015 |
Exhibit 10.16 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of this 9th day of March 2015, between Brenda Baron (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to continue to employ Executive, and Executive hereby accepts employment with the Company, upon the terms set forth |
|
| October 5, 2015 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Cor |
|
| October 5, 2015 |
Exhibit 10.17 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of this 9th day of March 2015, between Todd Silvestri (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to continue to employ Executive, and Executive hereby accepts employment with the Company, upon the terms set fort |
|
| October 2, 2015 |
IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2015 FINANCIAL RESULTS IMSC3Patents PR (EGS 5.8.15) (00359966).DOCX Exhibit 99.1 IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2015 FINANCIAL RESULTS Wilmington, MA ? September 28, 2015 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three months a |
|
| October 2, 2015 |
Form 8-K (M0592445.DOC;2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 2, 2015 (September 28, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisd |
|
| October 2, 2015 |
Implant Sciences Form 8-K (Current Report/Significant Event) Form 8-K (M0592445.DOC;2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 2, 2015 (September 28, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisd |
|
| October 2, 2015 |
EX-99.2 3 imsc151002ex99z2.htm EXHIBIT 99.2 EXHIBIT 99.2 CORPORATE PARTICIPANTS William McGann Implant Sciences Corporation - CEO Roger Deschenes Implant Sciences Corporation - CFO Robert Liscouski Implant Sciences Corporation - President CONFERENCE CALL PARTICIPANTS Mark Jordan Noble Financial - Analyst Patrick Moore Private Investor Sean Sullivan Private Investor PRESENTATION Operator Good day, |
|
| September 30, 2015 |
10-K 1 imsc15063010k.htm 150630 IMSC FORM 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001 |
|
| September 28, 2015 |
10-K 1 imsc15063010k.htm 150630 IMSC FORM 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001 |
|
| September 14, 2015 |
Implant Sciences 150630 IMSC FORM 12B-25 FOR FORM 10-K Form 12b-25 for 2009 Form 10-K (M0108789.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on |
|
| September 9, 2015 |
Form 8-K (President) (00382299-2).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 1, 2015 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction |
|
| September 9, 2015 |
IMSCSchiphol PR (00355826-2).DOCX Exhibit 99.1 As Implant Sciences Prepares for Growth as the Industry Leader of ETD, CEO Dr. Bill McGann Announces Robert Liscouski as President Dr. Bill McGann to continue to serve as CEO Wilmington, MA ? September 2, 2015 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for |
|
| July 7, 2015 |
Submission of Matters to a Vote of Security Holders 8-K 1 imsc1507078k.htm 150707 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July1, 2015 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of In |
|
| June 4, 2015 |
Implant Sciences 150602 IMSC DEF14A Proxy Statement (00362279-4).DOC X UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: ? Pre |
|
| June 2, 2015 |
Implant Sciences 150601 IMSC FORM SD Form 10-Q - 2014 Q1 (M0590221.DOC;3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Implant Sciences Corporation (Exact name of registrant as specified in its charter) Massachusetts 001-14949 04-2837126 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 500 Research |
|
| June 2, 2015 |
Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2014 Converted by EDGARwiz Exhibit 1.01 Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2014 1. Background The United States Securities and Exchange Commission (?SEC?) adopted rules, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (?Dodd-Frank?), that require us to file with the SEC a report disclosing whether our products contain |
|
| May 20, 2015 |
EX-99.2 3 imsc150520ex99z2.htm EXHIBIT 99.2 Exhibit 99.2 CORPORATE PARTICIPANTS Bill McGann Implant Sciences Corporation - CEO Roger Deschenes Implant Sciences Corporation - CFO Bob Liscouski Implant Sciences Corporation - EVP - Business Development CONFERENCE CALL PARTICIPANTS Mark Jordan Noble Financial - Analyst Patrick Mayor Investor Eric Panzik Private Investor PRESENTATION Operator Good day, |
|
| May 20, 2015 |
Form 8-K (M0592445.DOC;2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2015 (May 14, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of |
|
| May 20, 2015 |
IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2015 FINANCIAL RESULTS IMSC3Patents PR (EGS 5.8.15) (00359966).DOCX Exhibit 99.1 IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2015 FINANCIAL RESULTS Wilmington, MA ? May 14, 2015 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months end |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences Co |
|
| May 14, 2015 |
Implant Sciences 150511 IMSC PRE14A Implant Preliminary Proxy Statement (00357624-4).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant o Check the app |
|
| April 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 23, 2015 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (C |
|
| April 9, 2015 |
Implant Sciences 150409 IMSC FORM 8-K (Current Report/Significant Event) 8-K Item 5.08 (00353269).DOCX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 9, 2015 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorpora |
|
| March 25, 2015 |
Omnibus Twelfth Amendment (M0628422.DOC;2) Exhibit 10.2 OMNIBUS THIRTEENTH AMENDMENT TO CREDIT AGREEMENT AND FIFTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Thirteenth Amendment to Credit Agreement and Fifteenth Amendment to Note and Warrant Purchase Agreement (?Amendment?) is made as of the 19th day of March, 2015 between Implant Sciences Corporation, a Massachusetts corpo |
|
| March 25, 2015 |
CONSENT AND OMNIBUS AMENDMENT TO SECURED TERM NOTES Converted by EDGARwiz Exhibit 10.1 CONSENT AND OMNIBUS AMENDMENT TO SECURED TERM NOTES This Consent and Omnibus Amendment to Secured Term Notes (this ?Amendment?) is made as of March 19, 2015, by and between Implant Sciences Corporation, a Massachusetts corporation (?Company?), C Acquisition Corp., a Delaware corporation (?C Acquisition?), Accurel Systems International Corporation, a California co |
|
| March 25, 2015 |
Implant Sciences 150325 IMSC FORM 8-K (Current Report/Significant Event) Form 8-K for Tenth Omnibus Amendment (M0507610.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 25, 2015 (March 19, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS |
|
| March 25, 2015 |
IMSCCreditExtension PR (EGS 3.18.15) (00349711).DOCX Exhibit 99.1 Implant Sciences Extends Credit Agreements Credit Extension to Support Implant Sciences? Current Orders and Future Growth Wilmington, MA ? March 19, 2015 ? Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, toda |
|
| March 4, 2015 |
8-K 1 imsc1503048k.htm 150304 IMSC FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 4, 2015 (February 26, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State o |
|
| March 4, 2015 |
IMPLANT SCIENCES CORPORATION AMENDED AND RESTATED CHANGE OF CONTROL PAYMENT PLAN Exhibit 10.1 IMPLANT SCIENCES CORPORATION AMENDED AND RESTATED CHANGE OF CONTROL PAYMENT PLAN ARTICLE 1 Purpose 1.1 The purposes of the Plan are (a) to keep certain key employees and directors focused on the interests of the Company's shareholders and to secure their continued services in addition to their undivided dedication and objectivity in the event of any threat or occurrence of, or negotia |
|
| February 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 20, 2015 (February 17, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) |
|
| February 20, 2015 |
IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2015 FINANCIAL RESULTS Exhibit 99.1 IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2015 FINANCIAL RESULTS Wilmington, MA…February 17, 2015…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three and six months ended December 31, 2014. Revenues for the three months ended December 3 |
|
| February 20, 2015 |
Exhibit 99.2 Event ID: 141139452737 Culture: en-US Event Name: Q2 2015 Implant Sciences Corp Earnings Call Event Date: 2015-02-17T21:15:00 UTC ****************************************************** Notes: Converted From Text Transcript 141139452737 Q2 2015 Implant Sciences Corp Earnings Call February 17, 2015 C: William McGann; Implant Sciences Corporation; CEO C: Roger Deschenes; Implant Sciences |
|
| February 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences C |
|
| February 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 9, 2015 (February 5, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 00 |
|
| February 9, 2015 |
Exhibit 99.1 Implant Sciences Appoints Robert Liscouski as Executive Vice President Former Assistant Secretary for Infrastructure Protection, Department of Homeland Security joins Implant Sciences in new strategic role Wilmington, MA – February 9, 2015 – Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for hom |
|
| January 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2015 (January 16, 2015) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 00 |
|
| January 23, 2015 |
Implant Sciences Board Announces Appointment of Dr. William McGann as CEO Exhibit 99.1 Implant Sciences Board Announces Appointment of Dr. William McGann as CEO WILMINGTON, Mass., Jan. 20, 2015 - Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that Chief Operating Officer William McGann has been named as the Company's Chief Execu |
|
| January 23, 2015 |
SEPARATION AGREEMENT AND RELEASE Exhibit 10.1 SEPARATION AGREEMENT AND RELEASE This Agreement is being entered into as of January 16, 2015, between Implant Sciences Corporation (“ISC”), on behalf of and for the benefit of itself and all related corporate entities, and their divisions, affiliates (which means all persons and entities directly or indirectly or indirectly controlling, controlled by or under common control with ISC), |
|
| November 19, 2014 |
Exhibit 99.3 IMPLANT SCIENCES CORPORATION FIRST QUARTER FISCAL 2015 EARNINGS CONFERENCE CALL SCRIPT November 14, 2014 Glenn Bolduc - Implant Sciences Corp. – President and Chief Executive Officer Thank you. I'd like to welcome everyone to Implant Sciences' First Quarter Fiscal 2015 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call with me this afternoon |
|
| November 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 18, 2014 (November 13, 2014) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) |
|
| November 19, 2014 |
Exhibit 99.1 Implant Sciences Receives Order from TSA for 1,170 Explosive Trace Detectors QS-B220s to be deployed to multiple U.S. airports Wilmington, MA – November 13, 2014 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed a |
|
| November 19, 2014 |
IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2015 FINANCIAL RESULTS Exhibit 99.2 IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2015 FINANCIAL RESULTS Wilmington, MA… November 14, 2014…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months ended September 30, 2014. Revenues for the three months ended September 30, 201 |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences |
|
| October 28, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Cor |
|
| October 1, 2014 |
IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2014 FINANCIAL RESULTS EX-99.1 2 imsc141001ex99z1.htm EXHIBIT 99.1 Exhibit 99.1 IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2014 FINANCIAL RESULTS Wilmington, MA… September 29, 2014…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months and fiscal year ended June 30 |
|
| October 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 1, 2014 (September 29, 2014) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 0 |
|
| October 1, 2014 |
Exhibit 99.2 Event ID: 138661138489 Culture: en-US Event Name: Q4 2014 Implant Sciences Corp Earnings Call Event Date: 2014-09-29T20:15:00 UTC ****************************************************** Notes: Converted From Text Transcript 138661138489 Q4 2014 Implant Sciences Corp Earnings Call September 29, 2014 C: Glenn Bolduc; Implant Sciences Corporation; Chairman, President, CEO C: Roger Deschen |
|
| September 29, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Corporation (Exact name |
|
| July 8, 2014 |
IMPLANT SCIENCES CORPORATION 2014 STOCK OPTION PLAN EX-10.1 2 imsc140708ex10z1.htm EXHIBIT 10.1 Exhibit 10.1 IMPLANT SCIENCES CORPORATION 2014 STOCK OPTION PLAN 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 ESTABLISHMENT. The Implant Sciences Corporation 2014 Stock Option Plan (the “Plan”) is hereby established effective as of July 2, 2014, by adoption of the Company’s Board. Awards may be granted under the Plan with or without stockholder approv |
|
| July 8, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 2, 2014 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (Com |
|
| June 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Implant Sciences Corporation (Exact name of registrant as specified in its charter) Massachusetts 001-14949 04-2837126 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 500 Research Drive, Unit 3, Wilmington, Massachus |
|
| June 2, 2014 |
Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2013 Exhibit 1.02 Implant Sciences Corporation Conflict Minerals Report For the Year Ended December 31, 2013 1. Background The United States Securities and Exchange Commission (“SEC”) adopted rules, pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank’), that require us to file with the SEC a report disclosing whether our products contain certain “Conflict Mine |
|
| May 20, 2014 |
IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2014 FINANCIAL RESULTS EX-99.1 2 imsc140520ex99z1.htm EXHIBIT 99.1 Exhibit 99.1 IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2014 FINANCIAL RESULTS Wilmington, MA… May 15, 2014…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the fiscal quarter and nine month period ended March 31, |
|
| May 20, 2014 |
IMPLANT SCIENCES CORPORATION THIRD QUARTER FISCAL 2014 EARNINGS CONFERENCE CALL SCRIPT May 15, 2014 Exhibit 99.2 IMPLANT SCIENCES CORPORATION THIRD QUARTER FISCAL 2014 EARNINGS CONFERENCE CALL SCRIPT May 15, 2014 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' Third Quarter Fiscal 2014 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call this afternoon are Glenn Bolduc, President and Chief Executive Officer, Bill McGann, |
|
| May 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2014 (May 15, 2014) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences Corp |
|
| April 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2014 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (C |
|
| March 26, 2014 |
[FORM OF SENIOR SECURED PROMISSORY NOTE] EX-10.2 3 imsc140326ex10z2.htm EXHIBIT 10.2 Exhibit 10.2 [FORM OF SENIOR SECURED PROMISSORY NOTE] THE SECURITY REPRESENTED BY THIS CERTIFICATE (THE “SECURITY”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICAB |
|
| March 26, 2014 |
Exhibit 10.4 SECURITY AGREEMENT This SECURITY AGREEMENT (this “Agreement”), dated as of March 19, 2014, among the Grantor(s) listed on the signature pages hereof and those additional entities that hereafter become parties hereto by executing the form of Supplement attached hereto as Annex 1 (collectively, jointly and severally, the “Grantors” and each, individually, a “Grantor”), and BAM Administr |
|
| March 26, 2014 |
Exhibit 10.7 INTERCREDITOR AGREEMENT INTERCREDITOR AGREEMENT (this “Agreement”) dated as of March 19, 2014, by and between the First Lien Agent (such term, and each other term used but not defined in this preamble or in the recitals to this Agreement, having the meaning assigned thereto in Section 1), for itself and on behalf of the other First Lien Creditors, and the Second Lien Creditor, and ack |
|
| March 26, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 19, 2014 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (C |
|
| March 26, 2014 |
Exhibit 10.6 OMNIBUS TWELFTH AMENDMENT TO CREDIT AGREEMENT AND FOURTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Twelfth Amendment to Credit Agreement and Fourteenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 19th day of March, 2014 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a D |
|
| March 26, 2014 |
Exhibit 99.1 Implant Sciences Completes $20,000,000 Refinancing New non-convertible term loan used to pay down DMRJ debt Maturity of all indebtedness to DMRJ extended to March 31, 2015 Wilmington, MA – March 21, 2014 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the execution of a Note Purch |
|
| March 26, 2014 |
Exhibit 10.1 NOTE PURCHASE AGREEMENT DATED AS OF MARCH 19, 2014 BY AND BETWEEN IMPLANT SCIENCES CORPORATION AND THE INVESTORS PARTY HERETO AND BAM ADMINISTRATIVE SERVICES LLC TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF NOTE Section 1.1 Purchase and Sale of Note. Section 1.2 Closing. ARTICLE II REPRESENTATIONS AND WARRANTIES Section 2.1 Representations and Warranties of the Company. Secti |
|
| March 26, 2014 |
Exhibit 10.5 GUARANTY This GUARANTY (the “Guaranty”), dated as of March 19, 2014, is executed and delivered by C ACQUISITION CORP., a Delaware corporation (“C Acquisition”), ACCUREL SYSTEMS INTERNATIONAL CORPORATION, a California corporation (“Accurel”), and IMX ACQUISITION CORP., a Delaware corporation (“IMX” and together with C Acquisition and Accurel, each a “Guarantor” and collectively, “Guara |
|
| March 26, 2014 |
Exhibit 10.3 BAM Administrative Services LLC 1370 Avenue of the Americas 32nd Floor New York, New York 10019 March 19, 2014 Implant Sciences Corporation 500 Research Drive Unit 3 Wilmington, Massachusetts 01887 Attn: Glenn D. Bolduc, President Re: Note Purchase Agreement, dated as of March 19, 2014 (the “Agreement”), by and between Implant Sciences Corporation (the “Company”), each of the entities |
|
| February 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2014 (February 13, 2014) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) |
|
| February 19, 2014 |
Investor Call Script Exhibit 99.2 IMPLANT SCIENCES CORPORATION SECOND QUARTER FISCAL 2014 EARNINGS CONFERENCE CALL SCRIPT February 13, 2014 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' Second Quarter Fiscal 2014 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call this afternoon are Glenn Bolduc, President and Chief Exe |
|
| February 19, 2014 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2014 FINANCIAL RESULTS Significant Increases in QS-B220 Revenue Wilmington, MA… February 13, 2014…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the fiscal quarter and six month period ended December |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences C |
|
| November 18, 2013 |
Exhibit 99.1 Implant Sciences Extends Credit Agreements with DMRJ Group LLC DMRJ Cites TSA Air Cargo Screening Qualification and European Passenger and Cargo Screening Certification Wilmington, MA – November 14, 2013 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that it has renegotiated its credit agree |
|
| November 18, 2013 |
EX-10.1 2 imsc131118ex10z1.htm EXHIBIT 10.1 Exhibit 10.1 OMNIBUS ELEVENTH AMENDMENT TO CREDIT AGREEMENT AND THIRTEENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Eleventh Amendment to Credit Agreement and Thirteenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 14th day of November, 2013 between Implant Sciences Corporation, a Massachusetts cor |
|
| November 18, 2013 |
Exhibit 99.3 IMPLANT SCIENCES CORPORATION FIRST QUARTER FISCAL 2014 EARNINGS CONFERENCE CALL SCRIPT November 14, 2013 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' First Quarter Fiscal 2014 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call this afternoon are Glenn Bolduc, President and Chief Executive Officer and Bill |
|
| November 18, 2013 |
8-K 1 imsc1311188k.htm 13118 IMSC FORM 8-KDMRJ AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 18, 2013 (November 14, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASS |
|
| November 18, 2013 |
EX-99.2 4 imsc131118ex99z2.htm EXHIBIT 99.2 Exhibit 99.2 IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2014 FINANCIAL RESULTS Increased acceptance of QS B-220 by domestic and international freight forwarders Wilmington, MA… November 14, 2013…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today an |
|
| November 15, 2013 |
- 131115 IMSC FOMR 12B-25 FOR 130930 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10- |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences |
|
| October 28, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 28, 2013 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| October 28, 2013 |
TSA-Office of Security Technology Exhibit 99.2 TSA-Office of Security Technology 701 South 12th Street Arlington, Virginia 22202 Transportation Security Administration To: Todd Silvestri Vice President – Technology Implant Sciences Corporation From: Ms. Deborah Rooney Chairperson, Technical Review Panel Transportation Security Administration Date: October 18, 2013 Subject: Notification of Qualification Group (QG2) Submission Windo |
|
| October 28, 2013 |
Implant Sciences’ QS-B220 Explosives Trace Detector Receives “Qualified” Status for Air Cargo EX-99.1 2 imsc131028ex99z1.htm EXHIBIT 99.1 Exhibit 99.1 Implant Sciences’ QS-B220 Explosives Trace Detector Receives “Qualified” Status for Air Cargo Wilmington, MA – October 28, 2013 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) ha |
|
| October 28, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Cor |
|
| October 1, 2013 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2013 FINANCIAL RESULTS FY 2013 Revenues Increase 253% to $12.0 million Wilmington, MA… September 30, 2013…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the fiscal quarter and fiscal year ended J |
|
| October 1, 2013 |
Exhibit 99.2 IMPLANT SCIENCES CORPORATION FOURTH QUARTER FISCAL 2013 EARNINGS CONFERENCE CALL SCRIPT SEPTEMBER 30, 2013 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' Fourth Quarter Fiscal 2013 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call this afternoon are Glenn Bolduc, President and Chief Executive Officer, Bill |
|
| October 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 1, 2013 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 ( |
|
| September 30, 2013 |
Exhibit 10.17 The mailing, delivery or negotiation of this Lease shall not be deemed an offer to enter into any transaction or to enter into any relationship, whether on the terms contained herein or on any other terms. This Lease shall not be binding upon Landlord, nor shall Landlord have any obligations or liabilities with respect thereto, or with respect to the premises, unless and until Landlo |
|
| September 30, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Corporation (Name of sm |
|
| August 2, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events - 130802 IMSC FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2013 (July 30, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-149 |
|
| August 2, 2013 |
EX-99.1 2 imsc130802ex99z1.htm EXHIBIT 99.1 Exhibit 99.1 Implant Sciences Moves into 58,000 sq. ft. Manufacturing & Office Facility to Accommodate Anticipated Demand Wilmington, MA – July 30, 2013 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has moved its headquarters and manufactur |
|
| July 1, 2013 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is made as of this 25th day of June, 2013 between Glenn D. Bolduc (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to employ Executive, and Executive hereby accepts employment with the C |
|
| July 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 1, 2013 (June 25, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 |
|
| May 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences Corp |
|
| May 17, 2013 |
Exhibit 3.1 FEDERAL IDENTIFICATION NO. 04-2837126 THE COMMONWEALTH OF MASSACHUSETTS William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 RESTATED ARTICLES OF ORGANIZATION (General Laws, Chapter 156b, Section 74) We, Anthony J. Armini, President, and Stephen N. Bunker, Clerk, of Implant Sciences Corporation, located at 105 Audubon Road, #5, Wake |
|
| May 16, 2013 |
- 130516 IMSC FORM 12B-25 FOR 130331 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ |
|
| May 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 10, 2013 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (Com |
|
| May 14, 2013 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS THIRD QUARTER FISCAL 2013 FINANCIAL RESULTS Company to Host Earnings Call on Friday, May 10th at 1:00 PM EST Wilmington, MA… May 10, 2013…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the fiscal quarter and nine months e |
|
| May 14, 2013 |
IMPLANT SCIENCES CORPORATION THIRD QUARTER FISCAL 2013 EARNINGS CONFERENCE CALL SCRIPT MAY 10, 2013 Exhibit 99.2 IMPLANT SCIENCES CORPORATION THIRD QUARTER FISCAL 2013 EARNINGS CONFERENCE CALL SCRIPT MAY 10, 2013 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' Third Quarter Fiscal 2013 Earnings Conference Call. We also welcome those of you joining us on the webcast. On the call this afternoon are Glenn Bolduc, President and Chief Executive Officer, Bill McGann, |
|
| April 12, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 12, 2013 (April 11, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14 |
|
| April 12, 2013 |
Implant Sciences Corporation (IMSC.PK) Update Conference Call April 11, 2013 4:15 PM ET Exhibit 99.1 Implant Sciences Corporation (IMSC.PK) Update Conference Call April 11, 2013 4:15 PM ET Executives Glenn D. Bolduc – President and Chief Executive Officer Dr. Bill McGann – Chief Operating Officer Dr. Darryl Jones – Vice President, Global Sales and Marketing Analysts Joseph Munda – Sidoti & Company Daniel Small – Platinum Partners Jason Lutsch – Advanced Auto Glass Alan Shebesta – Reg |
|
| March 1, 2013 |
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE EX-10.2 4 imsc1303018kex10z2.htm EXHIBIT 10.2 Exhibit 10.2 THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR IMPLAN |
|
| March 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 1, 2013 (February 28, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001- |
|
| March 1, 2013 |
EX-10.1 3 imsc1303018kex10z1.htm EXHIBIT 10.1 Exhibit 10.1 OMNIBUS TENTH AMENDMENT TO CREDIT AGREEMENT AND TWELFTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Tenth Amendment to Credit Agreement and Twelfth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 28th day of February, 2013 between Implant Sciences Corporation, a Massachusetts corporation ( |
|
| March 1, 2013 |
EX-3.1 2 imsc1303018kex3z1.htm EXHIBIT 3.1 Exhibit 3.1 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 600 Research Drive, Wilmington, |
|
| February 14, 2013 |
Exhibit 3.1 FEDERAL IDENTIFICATION NO. 04-2837126 THE COMMONWEALTH OF MASSACHUSETTS William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 RESTATED ARTICLES OF ORGANIZATION (General Laws, Chapter 156b, Section 74) We, Anthony J. Armini, President, and Stephen N. Bunker, Clerk, of Implant Sciences Corporation, located at 105 Audubon Road, #5, Wake |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences C |
|
| February 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 31, 2013 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| February 4, 2013 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS SECOND QUARTER FISCAL 2013 FINANCIAL RESULTS Company to Host Earnings Call on Thursday, January 31st at 4:15 PM EST Wilmington, MA… January 31, 2013…Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the fiscal quarter and si |
|
| January 18, 2013 |
EX-3.1 2 imsc1301178kex3z1.htm EXHIBIT 3.1 EXHIBIT 3.1 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 600 Research Drive, Wilmington, |
|
| January 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 18, 2013 (January 16, 2013) IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 00 |
|
| January 18, 2013 |
3 JANUARY 16, 2013 / 06:30PM GMT, IMSC.QBB - Implant Sciences Corporation Update Conference Call Exhibit 99.1 THOMSON REUTERS STREETEVENTS EDITED TRANSCRIPT IMSC.QBB - Implant Sciences Corporation Update Conference Call EVENT DATE/TIME: JANUARY 16, 2013 / 06:30PM GMT 1 JANUARY 16, 2013 / 06:30PM GMT, IMSC.QBB - Implant Sciences Corporation Update Conference Call CORPORATE PARTICIPANTS Roger Deschenes Implant Sciences Corporation - CFO Glenn Bolduc Implant Sciences Corporation - President, CEO |
|
| January 16, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events - 130116_IMSC_FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 16, 2013 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| January 16, 2013 |
EX-99.1 2 imsc1301168kex99z1.htm EXHIBIT 99.1 Exhibit 99.1 Implant Sciences Receives TSA Approval QS-B220 Explosives Trace Detector Approved for Air Cargo Security Wilmington, MA – January 16, 2013 – Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administr |
|
| January 16, 2013 |
IMPLANT SCIENCES CORPORATION UPDATE CONFERENCE CALL SCRIPT January 16, 2013 EX-99.2 3 imsc1301168kex99z2.htm EXHIBIT 99.2 Exhibit 99.2 IMPLANT SCIENCES CORPORATION UPDATE CONFERENCE CALL SCRIPT January 16, 2013 CFO – Roger Deschenes Thank you. I'd like to welcome everyone to Implant Sciences' Update Conference Call. On the call this afternoon are Glenn Bolduc, President and Chief Executive Officer and Bill McGann, Chief Operating Officer. During this afternoon’s call, we |
|
| November 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File N |
|
| November 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File Nu |
|
| November 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File Numbe |
|
| November 19, 2012 |
EX-99.1 2 imsc1211198kex99z1.htm EX-99.1 Exhibit 99.1 IMPLANT SCIENCES REPORTS FIRST QUARTER FISCAL 2013 FINANCIAL RESULTS Company to Host Earnings Call on Thursday, November 15th at 4:15 PM EST Wilmington, MA… November 14, 2012…Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today an |
|
| November 19, 2012 |
8-K 1 imsc1211198k.htm 121119IMSC FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 14, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdict |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File No. 001-14949 Implant Sciences |
|
| October 29, 2012 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Cor |
|
| October 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 28, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-283712 |
|
| October 1, 2012 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS FOURTH QUARTER AND FISCAL 2012 FINANCIAL RESULTS Company to Host Earnings Call on Monday, October 1st at 10:00 AM EST Wilmington, MA… September 28, 2012…Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the four |
|
| September 28, 2012 |
EXHIBIT 21 SUBSIDIARIES OF IMPLANT SCIENCES CORPORATION State or Other Jurisdiction of: Name State of Other Jurisdiction of Incorporation or Organization C Acquisition Corp. Delaware Accurel Systems International Corporation California IMX Acquisition Corp. Delaware |
|
| September 28, 2012 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-14949 Implant Sciences Corporation (Name of sm |
|
| September 28, 2012 |
EXHIBIT 3.1 FEDERAL IDENTIFICATION NO. 04-2837126 THE COMMONWEALTH OF MASSACHUSETTS William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 RESTATED ARTICLES OF ORGANIZATION (General Laws, Chapter 156b, Section 74) We, Anthony J. Armini, President, and Stephen N. Bunker, Clerk, of Implant Sciences Corporation, located at 105 Audubon Road, #5, Wake |
|
| September 13, 2012 |
Exhibit 10.2 IMPLANT SCIENCES CORPORATION CHANGE OF CONTROL PAYMENT PLAN ARTICLE 1 Purpose 1.1 The purpose of the Plan is (a) to keep certain key employees and directors focused on the interests of the Company's shareholders and to secure their continued services in addition to their undivided dedication and objectivity in the event of any threat or occurrence of, or negotiation or other action th |
|
| September 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 7, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| September 13, 2012 |
Exhibit 99.1 Implant Sciences Grants New Stock Options to Senior Management and Board of Directors Adopts Change of Control Payment Plan Wilmington, MA – September 12, 2012 – Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for the homeland security and defense markets, today announced that it has granted new stock options to its senior management team a |
|
| September 13, 2012 |
IMPLANT SCIENCES CORPORATION AMENDMENT TO 2004 STOCK OPTION PLAN September 7, 2012 EX-10.1 2 bimscform8kex10z1.htm EXHIBIT 10.1 EXHIBIT 10.1 IMPLANT SCIENCES CORPORATION AMENDMENT TO 2004 STOCK OPTION PLAN September 7, 2012 This Amendment to the 2004 Stock Option Plan (this “Amendment”) of Implant Sciences Corporation, a Massachusetts corporation (the “Corporation”), is effective as of September 7, 2012. 1. Section 4.1 of the Corporation’s 2004 Stock Option Plan is hereby delete |
|
| September 11, 2012 |
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.2 THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR IMPLANT SCIENCES CORPORATION SHALL HAVE RECEIVED AN |
|
| September 11, 2012 |
EX-99.1 5 eimscform8kex99z1.htm EXHIBIT 99.1 Exhibit 99.1 Implant Sciences Extends Credit Agreements with DMRJ Group LLC and Converts a Portion of Credit Line Into Convertible Term Loan Wilmington, MA – September 5, 2012 – Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that it has renegotiated |
|
| September 11, 2012 |
EXHIBIT 3.1 The Commonwealth of Massachusetts William Francis Galvin Secretary of the Commonwealth One Ashburton Place, Boston, Massachusetts 02108-1512 Articles of Amendment (General Laws Chapter 156D, Section 10.06; 950 CMR 113.34) (1) Exact name of corporation: Implant Sciences Corporation (2) Registered office address: 600 Research Drive, Wilmington, MA 01887 (number, street, city or town, sta |
|
| September 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 5, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| September 11, 2012 |
EXHIBIT 10.1 OMNIBUS NINTH AMENDMENT TO CREDIT AGREEMENT AND ELEVENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Ninth Amendment to Credit Agreement and Eleventh Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 5th day of September, 2012 between Implant Sciences Corporation, a Massachusetts corporation (the “Company”), and DMRJ Group LLC, a Delawa |
|
| May 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 16, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (Com |
|
| May 22, 2012 |
Earnings Press Release - 2011 Q2 (M0266196.DOC;3) Exhibit 99.1 IMPLANT SCIENCES REPORTS THIRD QUARTER AND NINE MONTH FINANCIAL RESULTS Company to Host Earnings Call on Thursday May 17th at 4:15 pm EST Wilmington, MA… May 16, 2011…Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today a |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14949 Implant S |
|
| May 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (Comm |
|
| May 11, 2012 |
EX-99.1 3 f120511form8kex991revised.htm 120511IMSC FORM 8KJONES EMPLOYMENTEXHIBIT 99.1 Exhibit 99.1 Implant Sciences Appoints Darryl Jones as VP of Sales and Marketing Former Senior Executive at Company competitors Safran (Morpho Detection) and GE Security Wilmington, MA – May XX, 2012 – Continuing its record of attracting top industry talent, Implant Sciences Corporation (OTCQB: IMSC) (OTCPK: IMS |
|
| May 11, 2012 |
Employment Agreement - McGannafasdfa (M0387982.DOC;4) Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of this 7th day of March, 2012 between Darryl Jones (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to employ Executive, and Executive hereby accepts employment w |
|
| March 23, 2012 |
Exhibit 99.1 Implant Sciences Appoints Dr. Bill McGann as Chief Operating Officer Former Chief Technology Officer at GE Security and Pioneer in Trace Detection Industry Wilmington, MA – March 19, 2012 – Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced a significant executive management appointme |
|
| March 23, 2012 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of this 19th day of March, 2012 between William McGann (“Executive”) and Implant Sciences Corporation (the “Company”), a Massachusetts corporation. 1. Term of Employment. The Company hereby agrees to employ Executive, and Executive hereby accepts employment with the Company, upon the terms set forth in this A |
|
| March 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 19, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (C |
|
| March 16, 2012 |
Submission of Matters to a Vote of Security Holders - 120315_IMSC_FORM 8K_RESULTS OF SPECIAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 13, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (C |
|
| March 8, 2012 |
Implant Sciences Announces Resignation of Bruce R. Bower Exhibit 99.1 Implant Sciences Announces Resignation of Bruce R. Bower Wilmington, MA – March 8, 2012 – Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for homeland security markets, announces the resignation of Bruce R. Bower, on March 2, 2012. Mr. Bower had served as the Company’s Senior Vice President, Sales and Marketing since August 201 |
|
| March 8, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 2, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 (Co |
|
| February 24, 2012 |
Implant Sciences Extends Credit Line Facility extended to September 30, 2012 EX-99.1 3 imsc8kex99-1.htm 120224IMSCFORM 8KDMRJ CREDIT AGREEMENT AMENDMENT EXHIBIT 99.1 Exhibit 99.1 Implant Sciences Extends Credit Line Facility extended to September 30, 2012 Wilmington, MA – February 22, 2012 – Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that it has renegotiated its cr |
|
| February 24, 2012 |
EX-10.1 2 imsc8kex10-1.htm 120224IMSCFORM 8KDMRJ CREDIT AGREEMENT AMENDMENT EXHIBIT 10.1 Exhibit 10.1 OMNIBUS EIGHTH AMENDMENT TO CREDIT AGREEMENT AND TENTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT This Omnibus Eighth Amendment to Credit Agreement and Tenth Amendment to Note and Warrant Purchase Agreement (“Amendment”) is made as of the 21st day of February, 2012 between Implant Sciences C |
|
| February 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 21, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| February 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 17, 2012 IMPLANT SCIENCES CORPORATION (Exact name of Registrant as Specified in its Charter) MASSACHUSETTS (State or Other Jurisdiction of Incorporation) 001-14949 04-2837126 |
|
| February 21, 2012 |
Exhibit 99.1 IMPLANT SCIENCES REPORTS SECOND QUARTER AND SIX MONTH FINANCIAL RESULTS Company to Host Earnings Call on Tuesday February 21th at 4:15 pm EST Wilmington, MA… February 17, 2011…Implant Sciences Corporation (OTCQB:IMSC) (OTCPK:IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the second |
|
| February 16, 2012 |
- 120216_IMSC_DEF14A_120314 SPECIAL MEETING OF SHAREHOLDERS SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy S |
